NCT04311099 - Optimal Peripheral Nerve Block After Minimally Invasive Colon Surgery | Biotech Hunter

Enrollment

360

Participants

Timeline

Start Date

January 14, 2021

Primary Completion Date

February 8, 2024

Study Completion Date

March 31, 2024

Conditions

Pain, PostoperativePain, AbdominalAnalgesiaSurgeryColon CancerInjection Site

Interventions

DRUG

Active drug

Injection of Ropivacaine

DRUG

Placebo

Injection of Saline solution

PROCEDURE

Injection of Ropivacaine - Ultrasound-guided transverse abdominal plane block

Lateral ultrasound-guided transverse abdominal plane block 40 ml ropivacaine 2 mg / ml

PROCEDURE

Injection of Ropivacaine - Laparoscopic assisted transverse abdominal plane block

Laparoscopic assisted subcostal transverse abdominal plane block 40 ml ropivacaine 2 mg / ml

PROCEDURE

Injection of placebo - Ultrasound-guided transverse abdominal plane block

Lateral ultrasound-guided transverse abdominal plane block with saline solution

PROCEDURE

Injection of placebo - Laparoscopic assisted transverse abdominal plane block

Laparoscopic assisted subcostal transverse abdominal plane block with saline solution

Trial Locations (5)

Copenhagen University Hospital - Hvidovre, Hvidovre

Copenhagen University Hospital - North Zealand, Hillerød

Sydvestjysk Sygehus, Esbjerg

Regionshospitalet Herning, Herning

Regionshospitalet Viborg, Viborg

All Listed Sponsors

lead

Claus Anders Bertelsen, PhD, MD

OTHER